PepGen Reports First Quarter 2022 Financial Results and Recent Corporate Developments
June 16, 2022 08:30 ET
|
PepGen, Inc
BOSTON, June 16, 2022 (GLOBE NEWSWIRE) -- PepGen Inc. (“PepGen”), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the...
PepGen Announces Pricing of Initial Public Offering
May 05, 2022 23:34 ET
|
PepGen, Inc
BOSTON, May 05, 2022 (GLOBE NEWSWIRE) -- PepGen, Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment...